Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuf A Rajabally

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Muscle & Nerve|January 9, 2019
Cost of illness, cost of immunoglobulin therapy and their determinants in chronic inflammatory demyelinating polyneuropathyYusuf A Rajabally
Muscle & Nerve|May 21, 2022
Electrophysiology to identify disease mechanisms in CIDP: Reliability and valueYusuf A Rajabally
Immunotargets and Therapy|March 4, 2024
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future OutlooksYusuf A Rajabally
Muscle & Nerve|September 24, 2020
The "chronic immune polyradiculopathies": Diverse but maybe just CIDP after allYusuf A Rajabally
Neurodegenerative Disease Management|October 19, 2017
Unconventional treatments for chronic inflammatory demyelinating polyneuropathyYusuf A Rajabally
Muscle & Nerve|February 7, 2018
Chronic inflammatory demyelinating polyneuropathy misdiagnosis: A clinical more than electrophysiogical problem?Yusuf A Rajabally
Muscle & Nerve|January 6, 2015
Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathyYusuf A Rajabally
Muscle & Nerve|June 20, 2015
Reply: To PMID 25556954Yusuf A Rajabally
Journal of the Neurological Sciences|November 24, 2022
Chronic inflammatory demyelinating polyneuropathy: Reconciling guideline updating with increasing disease complexityYusuf A Rajabally
Journal of Neurology, Neurosurgery, and Psychiatry|October 15, 2013
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospectsYusuf A Rajabally
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Muscle & Nerve|January 9, 2019
Cost of illness, cost of immunoglobulin therapy and their determinants in chronic inflammatory demyelinating polyneuropathyYusuf A Rajabally
Muscle & Nerve|May 21, 2022
Electrophysiology to identify disease mechanisms in CIDP: Reliability and valueYusuf A Rajabally
Immunotargets and Therapy|March 4, 2024
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future OutlooksYusuf A Rajabally
Muscle & Nerve|September 24, 2020
The "chronic immune polyradiculopathies": Diverse but maybe just CIDP after allYusuf A Rajabally
Neurodegenerative Disease Management|October 19, 2017
Unconventional treatments for chronic inflammatory demyelinating polyneuropathyYusuf A Rajabally
Muscle & Nerve|February 7, 2018
Chronic inflammatory demyelinating polyneuropathy misdiagnosis: A clinical more than electrophysiogical problem?Yusuf A Rajabally
Muscle & Nerve|January 6, 2015
Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathyYusuf A Rajabally
Muscle & Nerve|June 20, 2015
Reply: To PMID 25556954Yusuf A Rajabally
Journal of the Neurological Sciences|November 24, 2022
Chronic inflammatory demyelinating polyneuropathy: Reconciling guideline updating with increasing disease complexityYusuf A Rajabally
Journal of Neurology, Neurosurgery, and Psychiatry|October 15, 2013
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospectsYusuf A Rajabally
Pageof 18